Monday Moody's Investors Service said it placed ratings for Chattem Inc. on review for a possible upgrade, which follows the company's announcement it is being bought for $1.9 billion by French drug developer Sanofi-Aventis SA.
Dear readers! Please observe community rules and respect each other. We do not practice censorship. However, all offensive comments will be deleted, and their posters will be blocked.